Subscribe

0

USFDA

Granules India Secures USFDA Approval for ADHD Treatment Capsules Sectors

Granules India Secures USFDA Approval for ADHD Treatment Capsules

This approval follows the company's recent December 2024 USFDA approval for Lisdexamfetamine Dimesylate Chewable Tablets, further expanding Granules' comprehensive portfolio in the ADHD therapeutic segment and demonstrating the company's commitment to providing multiple treatment options for patients.

By SMEStreet Edit Desk
Jan 30, 2025 17:23 IST 1 Min read
Taramjit Sandhu, Indian Ambassador, COVID-19 LimeLight
Indian Pharma Companies Have Important Role Against COVID19 Pandemic: Ambassador Taranjit Sandhu
By SMEStreet Desk
Apr 22, 2020 08:40 IST 3 Min read
Glenn Saldahna, Stock Market, BSE, Glenmark Pharmaceuticals, USFDA, Acid Reflux News
Glenmark Pharmaceuticals Gets USFDA Approval for Acid Reflux Medication
By SMEStreet Desk
May 14, 2019 11:38 IST 1 Min read
Robert Matsuk, Glenmark News
Glenmark Pharma Rises 3% on USFDA Approval for Monroe Facility
By SMEStreet Desk
Jun 19, 2018 06:03 IST 1 Min read
gv prasad, Dr Reddy News
Dr Reddy's Plan for Major Expansion in US Market
By SMEStreet Edit Desk
Jun 04, 2018 04:35 IST 1 Min read
N. Govindarajan, Aurobindo Pharma InFocus
Aurobindo Pharma Profit Rises 24% to Rs 585 Crore
By SMEStreet Desk
Aug 24, 2016 03:26 IST 2 Min read
Quadria Capital Led Consortium Acquires Stake in Concord Biotech News
Quadria Capital Led Consortium Acquires Stake in Concord Biotech
By SMEStreet Desk
Jul 05, 2016 07:53 IST 2 Min read
Pharma, Karnataka, MSMEs, News
Regulatory Approvals Delay are Major Concerns for Pharma Exports’ growth
By SMEStreet Desk
Jun 17, 2016 06:21 IST 3 Min read